ArticleCancers2024

Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology Center.

Severin Rodler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.